変形性関節症治療の市場規模、シェア、成長分析、解剖学別、薬剤タイプ別、治療タイプ別、流通チャネル別、地域別 - 産業予測、2025～2032年

変形性関節症治療市場規模は2023年に87億1,000万米ドルと評価され、2024年の94億5,000万米ドルから2032年には181億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.50%で成長する見通しです。

世界の変形性関節症治療市場は、主に変形性関節症の罹患率の上昇と高齢化によって力強い成長を遂げています。平均寿命が延びるにつれて、変形性関節症に罹患する高齢者が増え、効果的な管理戦略の需要が高まっています。ヘルスケアの進歩は、症状を緩和し患者のQOLを高めることを目的とした革新的な治療ソリューションの必要性に拍車をかけています。さらに、治療の選択肢や早期介入の重要性に対する認識が高まっていることも、市場の拡大に寄与しています。ヘルスケア提供者は、変形性関節症とその危険因子について患者を積極的に教育しており、早期診断と迅速な治療につながっています。このような意識の高まりが、変形性関節症治療製品に対する需要を促進し、市場動向をさらに推し進めています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• 特許分析

変形性関節症治療市場規模：解剖学別

• 市場概要
• 変形性膝関節症
• 変形性股関節症
• 手の変形性関節症
• 小関節変形性関節症

変形性関節症治療市場規模：薬剤タイプ別

• 市場概要
• 鎮痛剤
  • アセトアミノフェン
  • オピオイド
• 非ステロイド性抗炎症薬（NSAID）
  • イブプロフェン
  • ナプロキセン
• コルチコステロイド
  • 経口コルチコステロイド
  • 注射用コルチコステロイド
• 粘性補充剤
  • ヒアルロン酸
• その他
  • 変形性関節症治療（DMOAD）

変形性関節症治療市場規模：治療タイプ別

• 市場概要
• 投薬
• 手術
  • 関節置換術
  • 関節鏡検査
  • 骨切り術
• 治療
  • 理学療法
  • 作業療法

変形性関節症治療市場規模：流通チャネル別

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

変形性関節症治療市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Sanofi（France）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• Johnson & Johnson（USA）
• GlaxoSmithKline plc（UK）
• AbbVie Inc.（USA）
• Eli Lilly and Company（USA）
• Bayer AG（Germany）
• Merck & Co., Inc.（USA）
• Bristol Myers Squibb（USA）
• AstraZeneca plc（UK）
• Amgen Inc.（USA）
• Haleon plc（UK）
• Seikagaku Corporation（Japan）
• Ono Pharmaceutical Co., Ltd.（Japan）
• Assertio Holdings, Inc.（USA）
• Zimmer Biomet Holdings, Inc.（USA）
• Ferring Pharmaceuticals（Switzerland）
• Genascence Corporation（USA）

結論と推奨事項

Osteoarthritis Treatment Market size was valued at USD 8.71 Billion in 2023 and is poised to grow from USD 9.45 Billion in 2024 to USD 18.15 Billion by 2032, growing at a CAGR of 8.50% during the forecast period (2025-2032).

The global osteoarthritis treatment market is experiencing robust growth, primarily fueled by the rising incidence of osteoarthritis and an aging demographic. As life expectancy improves, more elderly individuals are becoming susceptible to this condition, thereby escalating the demand for effective management strategies. Advancements in healthcare have catalyzed the need for innovative treatment solutions aimed at alleviating symptoms and enhancing patient quality of life. Additionally, heightened awareness surrounding treatment options and the significance of early intervention are contributing to this market expansion. Healthcare providers are proactively educating patients about osteoarthritis and its risk factors, leading to earlier diagnosis and prompt treatment. This increasing awareness is driving the demand for osteoarthritis treatment products, further propelling market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Osteoarthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Osteoarthritis Treatment Market Segmental Analysis

Global Osteoarthritis Treatment Market is segmented by anatomy, drug type, treatment type, distribution channel and region. Based on anatomy, the market is segmented into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis and small joint osteoarthritis. Based on drug type, the market is segmented into analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, visco supplementation agents and others. Based on treatment type, the market is segmented into medication, surgery and therapy. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Osteoarthritis Treatment Market

The escalating prevalence of obesity worldwide plays a crucial role in the rising rates of osteoarthritis, thereby significantly influencing the osteoarthritis treatment market. As more individuals grapple with obesity, the incidence of osteoarthritis also climbs, prompting a heightened demand for effective treatment solutions. This trend is particularly evident as obese patients typically necessitate multifaceted strategies to manage their osteoarthritis symptoms. Consequently, the link between increasing obesity rates and the growing need for osteoarthritis treatments creates a compelling driver for market expansion, highlighting the urgent need for healthcare providers to offer targeted therapies and interventions to this affected population.

Restraints in the Osteoarthritis Treatment Market

One of the primary obstacles facing the osteoarthritis treatment market is the scarcity of disease-modifying therapies. Despite progress in research and treatment options, there is still an evident shortfall in effective therapies that can halt or alter the progression of osteoarthritis. This deficiency not only complicates the comprehensive management of the disease but also adversely affects the overall treatment success and quality of life for patients. Consequently, the lack of such innovative therapeutic approaches serves as a significant constraint, limiting potential advancements in the care and rehabilitation of individuals suffering from this debilitating condition.

Market Trends of the Osteoarthritis Treatment Market

The global Osteoarthritis Treatment market is witnessing a significant trend towards personalized and multimodal treatment strategies, reflecting a deeper understanding of the disease's complexity and varied patient responses. As the elderly population continues to grow, healthcare providers are moving away from traditional methods focused solely on pain management with NSAIDs and analgesics. Instead, they are increasingly incorporating physical therapy, lifestyle modifications, and innovative therapies such as biologics and regenerative medicine to create tailored treatment plans. This shift not only aims to alleviate symptoms but also to improve overall joint function and quality of life, positioning these personalized approaches at the forefront of osteoarthritis care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis

Global Osteoarthritis Treatment Market Size by Anatomy & CAGR (2025-2032)

• Market Overview
• Knee Osteoarthritis
• Hip Osteoarthritis
• Hand Osteoarthritis
• Small Joint Osteoarthritis

Global Osteoarthritis Treatment Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Analgesics
  • Acetaminophen
  • Opioids
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Ibuprofen
  • Naproxen
• Corticosteroids
  • Oral Corticosteroids
  • Injectable Corticosteroids
• Visco Supplementation Agents
  • Hyaluronic Acid
• Others
  • Disease-Modifying Osteoarthritis Drugs (DMOADs)

Global Osteoarthritis Treatment Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Medication
• Surgery
  • Joint Replacement
  • Arthroscopy
  • Osteotomy
• Therapy
  • Physical Therapy
  • Occupational Therapy

Global Osteoarthritis Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Osteoarthritis Treatment Market Size & CAGR (2025-2032)

• North America (Anatomy, Drug Type, Treatment Type, Distribution Channel)
  • US
  • Canada
• Europe (Anatomy, Drug Type, Treatment Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Anatomy, Drug Type, Treatment Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Anatomy, Drug Type, Treatment Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Anatomy, Drug Type, Treatment Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haleon plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seikagaku Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ono Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Assertio Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genascence Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations